why choose us

First received: August 18, 2024

Clinical Trial: Relationship Between Serum ?2-Microglobulin and Infiltration of CD8+ in the Tumor Tissue of Hodgkin's Lymphoma Patients

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hodgkin Lymphoma

Study Type: OBSERVATIONAL


Official Title: The Relationship Between Serum Beta-2 Microglobulin (sB2M) Levels and CD8+ Cell Infiltration in Hodgkin Lymphoma Tissues: Impact on Chemotherapy Outcomes

Brief Summary: In newly diagnosed Hodgkin lymphoma patients, pre-treatment Beta-2 Microglobulin (B2M) levels will be measured.A thorough baseline assessment will be performed using CT imaging, and tumor tissue samples will be collected for Immunohistochemical (IHC) analysis to quantify CD8+ cell infiltration.Patients will be closely monitored throughout their treatment, with a follow-up CT scan at the end of therapy to evaluate therapeutic response.This study aims to investigate the correlation between pre-treatment B2M levels…

Read more